SoP LibraryOlecranon bursitis

Statement of Principles

Olecranon bursitis — DVA SoP factors

Every factor in the Repatriation Medical Authority Statements of Principles for Olecranon bursitis. DVA can only accept a claim for Olecranon bursitis if at least one of these factors is met and connected to your service. Reasonable Hypothesis (RH) applies to operational service; Balance of Probabilities (BoP) applies to peacetime service.

Source: Repatriation Medical Authority Statements of Principles as held by the Veterans Health Centre. SoPs are amended and replaced regularly; always confirm the current instrument at rma.gov.au before relying on it.

Olecranon bursitis

RH No. 63 of 2018 · BoP No. 64 of 201830 factors

Meaning of olecranon bursitis: For the purposes of this Statement of Principles, olecranon bursitis means inflammation or infection of the bursa overlying the olecranon process of the ulna.

Reasonable Hypothesis (RH) — Statement of Principles No. 63 of 2018

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting olecranon bursitis or death from olecranon bursitis with the circumstances of a person's relevant service:

  1. (1)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical onset of olecranon bursitis;
  2. (2)
    having trauma to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  3. (3)
    having surgery to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;
  4. (4)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical onset of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  5. (5)
    having a disorder from the specified list of disorders at the time of the clinical onset of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  6. (6)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical onset of olecranon bursitis;
  7. (7)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical onset of olecranon bursitis;
  8. (8)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical worsening of olecranon bursitis;
  9. (9)
    having trauma to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  10. (10)
    having surgery to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;
  11. (11)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical worsening of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  12. (12)
    having a disorder from the specified list of disorders at the time of the clinical worsening of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  13. (13)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical worsening of olecranon bursitis;
  14. (14)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical worsening of olecranon bursitis;
  15. (15)
    inability to obtain appropriate clinical management for olecranon bursitis;

Aggravation-only factors: the factors in subsections 8(8) to 8(15) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

Balance of Probabilities (BoP) — Statement of Principles No. 64 of 2018

15 factors

At least one of the following factors must exist before it can be said that, on the balance of probabilities, olecranon bursitis or death from olecranon bursitis is connected with the circumstances of a person's relevant service:

  1. (1)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical onset of olecranon bursitis;
  2. (2)
    having trauma to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  3. (3)
    having surgery to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;
  4. (4)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical onset of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  5. (5)
    having a disorder from the specified list of disorders at the time of the clinical onset of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  6. (6)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical onset of olecranon bursitis;
  7. (7)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical onset of olecranon bursitis;
  8. (8)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical worsening of olecranon bursitis;
  9. (9)
    having trauma to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  10. (10)
    having surgery to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;
  11. (11)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical worsening of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  12. (12)
    having a disorder from the specified list of disorders at the time of the clinical worsening of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  13. (13)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical worsening of olecranon bursitis;
  14. (14)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical worsening of olecranon bursitis;
  15. (15)
    inability to obtain appropriate clinical management for olecranon bursitis;

Aggravation-only factors: the factors in subsections 8(8) to 8(15) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

A VHC Diagnostic Assessment addresses each of these factors one by one against your service record and clinical history. See how a VHC DVA claim works, see all fees ($600 + GST per stage) or book an appointment.

About Dr Thomas Perkins

One doctor. Every report.

Founding doctor of the Veterans Health Centre in Ipswich, Queensland, and one of Australia's most experienced practitioners in veterans' medicolegal medicine.

Dr Perkins has spent more than thirteen years working exclusively with current and former ADF members — treating their conditions, writing their reports and navigating the DVA system alongside them. With over 100,000 claims submitted and 2,000 Permanent Impairment Assessments completed, he has seen precisely what separates an accepted claim from a rejected one at every level, from initial liability to the Veterans' Review Board.

Every chart review, diagnostic assessment, impairment rating and appeal that leaves this clinic is personally overseen by Dr Perkins. No template, no locum, no hand-off.

0429 146 039 reception@vhc.org.au

Book appointment